I'm a newbie when it comes to TA, but I've been following ELN for years. Look for a big earnings surprise next week -- with all the attention on Tysabri, people consistently underestimate the value of the company as a drug delivery/nanotechnology play. Also, ELN and Biogen have said they'll complete safety review of Tysabri by end of summer, and CEO has never wavered from statement that the drug will be back on the market by Q3. Next few weeks and months should bring a huge stream of good news to go with the technicals you guys are seeing.
Sapphocles
P.S. Cumuliina, the lawsuit PR is nothing to worry about -- just a final shakeout before earnings IMO.
Sapphocles
P.S. Cumuliina, the lawsuit PR is nothing to worry about -- just a final shakeout before earnings IMO.
